Nancy Bartlett, MD
Nancy Bartlett, MD, is the Komen Chair in Medical Oncology at Washington University School of Medicine. For the last 25 years her research has focused on the design, conduct, and analysis of clinical trials evaluating new treatments for patients with lymphoma. She has served as the Principal Investigator of the Washington University CALGB/Alliance U10/LAPS grant for the last 20 years. She has served as the vice-chair of the CALGB/Alliance Lymphoma Committee for more than 10 years, where she has served as principal investigator or co-principal investigator of several Phase II studies and mentored young investigators during trial design and interpretation. As head of the Lymphoma Program at Washington University, she also oversees the lymphoma clinical research team including a team of 13 clinical research assistants. In addition, she personally enrolls and treats more than 60 patients a year on therapeutic clinical trials allowing her to better understand the impact of trial design on study feasibility and conduct. This also provides her an opportunity to mentor and educate trainees and young faculty about the importance of clinical trials.